期刊文献+

古抑菌素对人肝癌细胞作用的研究

Study of effect of TSA on human hepatocellular carcinoma cells
下载PDF
导出
摘要 目的:通过组蛋白去乙酰化酶(histone deacetylase,HDACS)抑制剂古抑菌素A(Trichostatin A,TSA)对人肝癌细胞HepG2(以下简称HepG2)和正常肝细胞LO2(以下简称LO2)增殖与凋亡作用的比较,探讨TSA对肝癌的作用机制。方法:应用光学显微镜、透射电镜、四氮唑蓝(MTT)法、免疫细胞化学法观察经不同浓度TSA处理后的HepG2和LO2的增殖、凋亡与凋亡相关蛋白的改变。结果:HepG2细胞经TSA处理后,电镜下超微结构发生了凋亡早期改变;小剂量TSA对HepG2细胞具有较强的抑制作用,对LO2细胞影响不明显,当TSA浓度达到1000nmol/L以上时,对LO2表现出明显的细胞毒性作用;TSA可诱导HepG2细胞凋亡,并增加凋亡相关蛋白Bax的表达。结论:TSA可明显抑制肝癌细胞HepG2的增殖,其机制可能与上调Bax的表达,诱导细胞凋亡有关。 Objective:To investigate the mechanism of trichostatin A (TSA) by comparing the effects of TSA on the proliferation and apotosis of human hepatocellular carcinoma HepG2 cells and normal hepatocellular LO2 cells. Methods:MTT,phase-contrast-microscope,electron-microscopy, immunocytochemistry were conducted to observe the alteration of cell proliferation, apotosis and apoptosis-related protein of HepG2 and L02 after treated with TSA.Results:The HepG2 ceils altered in their cells forms and the early apoptosis was observed under electron microscope. Low dosage TSA had a very strong inhibition to HepG2 cells, nearly no efficacy on LO2 cells. When the TSA concentration of 1000nmol/L or above,the apparent cytotoxicity appeared to LO2 cells. TSA could induce the apoptosis of HepG2 cells and increase the expressions of bax. Conclusion:TSA can inhibit the proliferation of HepG2 cells. This maybe related to cell apoptosis by upmodulating the expression of Bax.
出处 《现代医药卫生》 2010年第15期2248-2250,共3页 Journal of Modern Medicine & Health
基金 四川省卫生厅科研项目 编号:060065
关键词 肝癌 组蛋白去乙酰化酶 古抑菌素A 细胞凋亡 Hepatoma Histone deacetylase TSA Apoptosis
  • 相关文献

参考文献7

二级参考文献26

  • 1赵洁,苏琦.组蛋白乙酰化/去乙酰化与白血病的研究进展[J].肿瘤学杂志,2004,10(6):436-439. 被引量:19
  • 2喻建华,万会平.原发性肝癌的介入治疗及其预后的影响因素[J].肿瘤防治杂志,2004,11(12):1309-1312. 被引量:3
  • 3张波,刘科,陈道达.曲古菌素A对结肠癌Lovo细胞增殖抑制的研究[J].中国普通外科杂志,2007,16(6):574-576. 被引量:4
  • 4Wang JJ,Chang YF,Chern YT,et al.Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy) phenyl]diamantane (DPD),a novel cytostatic and differentiation inducing agent,on human colon cancer cells[J].Br J Cancer,2003,89(10):1995 -2003.
  • 5Monneret C.Histone deacetylase inhibitors[J].Eur J Med Chem,2005,40(1):1 - 13.
  • 6Roy S,Packman K,Jeffrey R,et al.Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells[J].Cell Death Differ,2005,12:482 - 491.
  • 7Duan H,Heckman CA,Boxer LM.Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas[J].Mol Cell Biol,2005,25(5):1608-1619.
  • 8Chiba T,Yokosuka O,Fukai K,et al.Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor,trichostatin A,on human hepatoma cells[J].Oncology,2004,66(6):481 -491.
  • 9Juan LJ,Shia WJ,Chen MH,et al.Histone deacetylases specifically down-regulate p53-dependent gene activation[J].J Biol Chem,2000,275 (27):20436 - 20443.
  • 10Chiba T,Yokosuka O,Arai M,et al.Identification of genes upregulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells[J].J Hepatol,2004,41 (3):436 - 445.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部